Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues.
Florea L, Song L, Salzberg SL. · 2013
Read Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues. by Florea L, Song L, Salzberg SL. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3892928.txt.
Introduction
Liliana Florea, Li Song, and Steven L. Salzberg catalog gene splicing across human tissues in F1000Research in 2013. Cells can skip parts of a gene's message, called exons, to make varied proteins from one gene. The full range of that variation in healthy tissues was still unmapped.
Their software, ASprofile, mined a huge public RNA data set spanning sixteen human tissues. It found tens of thousands of likely exon skipping events that differ by tissue. Most were new to science, with new exons and new gaps. Only a small share flipped cleanly between tissue pairs, while many were absent from one or both. New events proved more tissue-specific than known ones. The catalog is a first draft of normal human splicing variety.
Catalog record
| CREATOR | Florea L, Song L, Salzberg SL. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues By Liliana Florea, Li Song, Steven L Salzberg Published in: F1000Research DOI: 10.12688/f1000research.2-188.v2 ABSTRACT Abstract Alternative splicing is widely recognized for its roles in regulating genes and creating gene diversity. However, despite many efforts, the repertoire of gene splicing variation is still incompletely characterized, even in humans. Here we describe a new computational system, ASprofile, and its application to RNA-seq data from Illumina’s Human Body Map project (>2.5 billion reads). Using the system, we identified putative alternative splicing events in 16 different human tissues, which provide a dynamic picture of splicing variation across the tissues. We detected 26,989 potential exon skipping events representing differences in splicing patterns among the tissues. A large proportion of the events (>60%) were novel, involving new exons (~3000), new introns (~16000), or both. When tracing these events across the sixteen tissues, only a small number (4-7%) appeared to be differentially expressed (‘switched’) between two tissues, while 30-45% showed little variation, and the remaining 50-65% were not present in one or both tissues compared. Novel exon skipping events appeared to be slightly less variable than known events, but were more tissue-specific. Our study represents the first effort to build a comprehensive catalog of alternative splicing in normal human tissues from RNA-seq data, while providing insights into the role of alternative splicing in shaping tissue transcriptome differences. The catalog of events and the ASprofile software are freely available from the Zenodo repository ( http://zenodo.org/record/7068; doi: 10.5281/zenodo.7068) and from our web site http://ccb.jhu.edu/software/ASprofile. BACKGROUND Alternative splicing is a widespread phenomenon in eukaryotic species, and differential regulation of alternative splice variants is gaining recognition as an important mechanism of gene regulation. More than 90% of human genes are estimated to be alternatively spliced 1, 2, producing multiple transcripts and (often) different protein sequences from a single locus. The number of variants of a gene ranges from two to potentially thousands 3. The resulting proteins may exhibit different and sometimes antagonistic functional and structural properties 4, and may inhabit the same cell with the resulting phenotype representing a balance between their expression levels 5. Defects in splicing have been implicated in human diseases, including cancer 6– 9. Developing a comprehensive catalog of splice variant annotations across a wide range of tissues and conditions is important not only as part of our efforts to create a complete gene list for the human genome, but also to serve as a reference for differential expression studies aiming to identify molecular markers of disease. Annotation of alternative splicing has traditionally been based on cDNA (expressed sequence tags (EST), mRNA) sequence data from public repositories such as dbEST, RefSeq 10, and the Mammalian Gene Collection 11. These data sources were compiled over many years, from independent contributions by thousands of investigators working on different genes and systems, and are therefore inconsistent in their coverage of the transcriptome in general and of each gene individually. Because these resources were generated using Sanger sequencing, they were relatively expensive to produce, but despite the cost have insufficient depth to capture the diversity of splicing variations in human cells. RNA-seq technology produces vastly more sequence data in a cost-effective way and in a much shorter amount of time, allowing a deep characterization of the transcriptome in a variety of cells and conditions 2, 12, 13, but so far little has been done to systematically assess its potential 14. Starting from one of the most complete sets of RNA-seq data available, the Illumina Human Body Map, we addressed the questions: "how much alternative splicing do we find?" and "how does alternative splicing vary among tissues?" We used this data set, spanning 16 tissues and containing over 2.5 billion sequences, to build a comprehensive catalog of alternative splicing (AS) within each tissue. We also compared AS profiles across tissue types to derive insights into the role of AS in shaping transcriptome differences. RESULTS We analyzed the Illumina Human Body Map RNA-seq set (ArrayExpress accession: E-MTAB-513; http://www.ebi.ac.uk/arrayexpress), consisting of approximately 160 million reads from each of 16 tissues, each from a different individual. This resource is one of the most high-quality and complete to date, and therefore allows us to detect AS events with high accuracy. To determine splicing variations in each tissue, we first mapped reads to the reference genome and assembled them into transcripts or transcript fragments. We then analyzed the transcripts to determine putative alternative splicing events, in particular exon skipping events, within and between samples, and compared them across the tissues. We focused on exon skipping because the alignment evidence for these events is usually clear and unambiguous, and less likely to be confounded by alignment or assembly artifacts. The data support a number of overall findings: 1. Based on a comparison against several annotation databases (Ensembl 15, CCDS 16, UCSC Genes 17 and H-ASDB 18), we found that 11–45% of the assembled transcripts in each tissue were unannotated, as well as a majority (65%) of the 26,989 exon skipping events discovered from this data set. 2. These novel events appear to be more tissue-specific than previously annotated (known) events; i.e., they tend to occur in fewer tissue types. 3. When an exon is skipped, it usually occurs in a different tissue from those in which it is present; only 5–23% of events express both forms within the same tissue. 4. Comparing exon skipping profiles across tissues, we found that only 10–20% of the events identified show different splicing ratios between any two given tissues, whereas 50–65% of the cataloged events are not present in either or both tissues. Overall, our analysis reveals a complex and dynamic picture of alternative splicing across tissue types, where differences among tissue transcriptomes arise from the interplay between constitutive transcription and alternative splicing. Most importantly, we compiled the first large repository of putative exon skipping and other classes of alternative splicing events in normal human tissues detected from RNA-seq data, which will be a valuable resource for studies of regulation and to identify markers of diseases. This catalog and our methods, implemented in the open source software program ASprofile, are freely available under the GNU GPL license from the Zenodo repository ( http://zenodo.org/record/7068; doi:10.5281/zenodo.7068) and from our web site http://ccb.jhu.edu/software/ASprofile. A global view of alternative splicing in the 16 tissues To determine alternative splicing events and globally characterize alternative splicing within a given tissue, we analyzed 50-bp paired-end sequences from 16 different tissues: adrenal, adipose, brain, breast, colon, heart, kidney, liver, lung, lymph, ovary, prostate, skeletal muscle, testes, thyroid and white blood cells. These data are publicly available as the Illumina Human Body Map project (EMBL accession ENA-ERP000546; ArrayExpress accession: E-MTAB-513; http://www.ebi.ac.uk/arrayexpress/browse.html?keywords=E-MTAB-513&expandefo=on). Libraries were made from polyA-selected mRNA with an insert size of 210 bp, independently for each tissue, using a random priming process and unstranded. One run of 2x50 bp paired-end sequencing was performed on the Illumina HiSeq2000 instrument, using one lane per tissue, to produce approximately 80 million pairs of reads (160 million sequences) per tissue. The entire data set comprises ~128 gigabases (GB) of sequence (~8 GB sequence per tissue), making this one of the most complete RNA-seq resources to date and one of very few